A drug currently prescribed to treat psoriasis could help treat the early stages of Type 1 diabetes in children and young people without the need for insulin, a new study finds.
The study, published in Nature Medicine, found that ustekinumab, an established immunotherapy drug used since 2009, can target the immune cells driving Type 1 diabetes.





